Papua New Guinea: Establishment of Pilot HIV/AIDS Care Centers. ADB (2005)

Papua New Guinea: Establishment of Pilot HIV/AIDS Care Centers. ADB (2005) ince 1987, 9851 cases have been reported as HIV positive out of a total population of 5.4 millions (June, 2004). From consensus workshop in November, 2004, an estimated number of HIV positive among 15-49 year age group was between 45,000- 75,000 cases. Among reported case, 52.0 % were male and 48.0% were female. Heterosexual (79.9%) is the predominant mode of transmission, 93.6 % is adult. The majority of HIV/AIDS cases have been found in the National Capital District (60.8 %) and Western Highland (14,3 %) province.

Download this publication

Indonesia: Summary Country Profile for HIV/AIDS Treatment Scale up. WHO (2005)

Indonesia: Summary Country Profile for HIV/AIDS Treatment Scale up. WHO (2005) The epidemic in Indonesia is concentrated, with low infection rates in the general population and high rates among certain populations, mainly injecting drug users and sex workers in some regions. Transmission among injecting drug users has increased eight-fold since 1998, and rates are as high as 70% among injecting drug users in Jakarta in 2005 (according to Kios Atmajaya, a nongovernmental organization) and 53% in Denpasar (Bali) and 26% among sex workers in one brothel in Papua.

Download this publication

Guidelines for the Use of Antiretroviral Therapy in HIV Positive Adults and Adolescents in Pakistan. National AIDS Control Program Pakistan (2005)

Guidelines for the Use of Antiretroviral Therapy in HIV Positive Adults and Adolescents in Pakistan. National AIDS Control Program Pakistan (2005) Successful treatment of HIV/AIDS depends on strict adherence by HIV positive patients in taking their medications as instructed and for health care providers to recommend antiretroviral treatment (ART) based on rigorous scientific evidence. The devastating consequences of incorrect or partial HIV treatment are premature death, increased morbidity, development of drug resistant HIV strains, and lack of further treatment options.

Download this publication

Technical Assistance to the Greater Mekong Subregion for HIV/AIDS Vulnerability and Risk Reduction among Ethnic Minority Groups through Communication Strategies. ADB (2005)

Technical Assistance to the Greater Mekong Subregion for HIV/AIDS Vulnerability and Risk Reduction among Ethnic Minority Groups through Communication Strategies. ADB (2005) Developing human resources and skills competencies is the Eighth Flagship Program under the Greater Mekong Subregion (GMS) program strategic framework. The GMS Regional Cooperation Strategy and Program (RCSP, March 2004) aims to reduce poverty through enhanced connectivity, increased competitiveness, and a greater sense of community. The RCSP emphasizes the need to take precautions against the negative impacts associated with these developments, such as communicable disease transmission, environmental degradation, and illegal trafficking. Many of these issues disproportionately affect vulnerable groups such as women, children, and ethnic minorities. At the 13th GMS Ministerial Meeting in December 2004, the GMS governments highlighted the prevention of the transmission of communicable diseases across borders, with particular attention to the developing threat of HIV/AIDS.

Download this publication

Baseline Characteristics of Patients Attending the SHC in the First 3 1⁄2 Months of Clinic Operation. National Centre for HIV/AIDS Dermatology and STD Cambodia and Social Health Clinic (2005)

Baseline Characteristics of Patients Attending the SHC in the First 3 1⁄2 Months of Clinic Operation. National Centre for HIV/AIDS Dermatology and STD Cambodia and Social Health Clinic (2005) National Center for HIV AIDS, Dermatology and STI’s (NCHADS)
Social Health Clinic (SHC)
Baseline characteristics of patients attending the SHC in the first 3 1⁄2 months of clinic operation.

Download this publication

Progress on Global Access to HIV Antiretroviral Therapy. UNAIDS and WHO (2005)

Progress on Global Access to HIV Antiretroviral Therapy. UNAIDS and WHO (2005) Since late 2003, when WHO and UNAIDS launched a strategy for ensuring treatment for 3 million people living with HIV/AIDS in low- and middle-income countries by the end of 2005 (the “3 by 5” target), coverage of antiretroviral therapy (ART) in these countries has more than doubled – increasing from 400 000 to approximately 1 million people receiving treatment at the end of June 2005. To date, 14 of these countries are providing ART to at least 50 per cent of those who need it, consistent with the “3 by 5” target.

Download this publication

China: Summary Country Profile for HIV/AIDS Treatment Scale-Up. WHO (2005)

China: Summary Country Profile for HIV/AIDS Treatment Scale-Up. WHO (2005) China has a low overall HIV prevalence but high prevalence in certain population groups and at some sites. WHO/UNAIDS estimated that 840 000 people in 0–49 years old were living with HIV/AIDS at the end of 2004, and the estimated HIV prevalence was 0.07% (with a low estimate of 0.05% and a high estimate of 0.08%). There are geographical differences in prevalence levels within subpopulations. Since 2001, reported HIV/AIDS cases have increased at a 30% annual rate, most likely as a result of increased surveillance. HIV is reported from 31 of China’s 34 provinces and other administrative units on mainland China.

Download this publication

HIV/AIDS Epidemic in India: Risk Factors, Risk Behavior & Strategies for Prevention & Control. Godbole S and Mehendale S (2005)

HIV/AIDS Epidemic in India: Risk Factors, Risk Behavior & Strategies for Prevention & Control. Godbole S and Mehendale S (2005) Since the first report of HIV infection in India in 1986, the virus has spread all over the country although there is geographic variation. There are estimated 5.1 million people infected with HIV with an overall estimated adult prevalence below 1 per cent. Surveys carried out in different sub-populations have yielded prevalence estimates, but data on HIV incidence are limited. Both HIV serotypes 1 and 2 exist in India and HIV-1 C is the commonest subtype reported. Sexual transmission of HIV is most predominant. Spread of HIV in intravenous drug use settings is localized mostly in the north eastern region and metropolitan cities and parent to child transmission is on the rise.

Download this publication

Myanmar: Summary Country Profile for HIV/AIDS Treatment Scale up. WHO (2005)

Myanmar: Summary Country Profile for HIV/AIDS Treatment Scale up. WHO (2005) With national estimated prevalence of between 0.6% and 2.2%, Myanmar is experiencing a generalized epidemic, considered one of the most serious in Asia. The Ministry of Health estimates that 338 911 adults aged 15–49 years old were living with HIV/AIDS in September 2004, of which 96 834 (28.6%) were women, indicating a total adult prevalence rate of 1.3%. HIV infection rates vary across the country, with several regions showing considerable increases in prevalence rates among less vulnerable populations. According to the Ministry of Health, in 2003, 12 of 29 sentinel sites for pregnant women showed a prevalence of HIV infection exceeding 2%. At Pyay and Hpa-an, prevalence rates among pregnant women were as high as 5% and 7.5% respectively.

Download this publication

Project Performance Assessment Report Indonesia: Indonesia HIV/AIDS and STDs Prevention and Management Project. The World Bank (2005)

Project Performance Assessment Report Indonesia: Indonesia HIV/AIDS and STDs Prevention and Management Project. The World Bank (2005) The Operations Evaluation Department assesses the programs and activities of the World Bank for two purposes: first, to ensure the integrity of the Bank’s self-evaluation process and to verify that the Bank’s work is producing the expected results, and second, to help develop improved directions, policies, and procedures through the dissemination of lessons drawn from experience. As part of this work, OED annually assesses about 25 percent of the Bank’s lending operations.


Download this publication

Pages

database
Highlighted publications
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Monitoring_2018.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017_Data_2017_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_cities_ending_the_aids_epidemic_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Fact_Sheets_Nov2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Mar
24
(24 Mar - 24 Mar)
Apr
7
(7 Apr - 7 Apr)
May
17
(17 May - 17 May)